BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, May 5, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for May 26, 2023

May 26, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Annexon, Antabio, Apellis, Bial, Bioinvent, Bioxcel, Harmony, Immutep, Jaguar, Lynk, Onconova, Stallergenes, Stemcyte, Topas, Transgene, Vanda.
Read More

In the clinic for May 25, 2023

May 25, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biosency, Biospectal, Bonesupport.
Read More

In the clinic for May 25, 2023

May 25, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aerami, Allgenesis, Alimera, Alzecure, Clarity, Curium, Cybin, Daiichi, Eloxx, Galapagos, Geovax, Immunos, Immutep, Innovative Cellular, Lassen, Lisata, Mereo, Peptilogics, Pliant, PTC, Quoin, Thermosome, Trialspark.
Read More

In the clinic for May 24, 2023

May 24, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, Clarity, Preludedx, Screenpoint Medical, Stryker.
Read More

In the clinic for May 24, 2023

May 24, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, Acepodia, Achieve, Anamar, Arrowhead, Avalyn, Blueprint, Galecto, Hibercell, Hillhurst, Icosavax, MEI, Minghui, NMD, Rakuten, Trevi, Upstream, Valbiotis, Valo, Wave.
Read More

In the clinic for May 23, 2023

May 23, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anuncia Medical, Cytovale, Moleculight; Moximed.
Read More

In the clinic for May 16-22, 2023

May 23, 2023
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Carsgen, Delta-Fly, Everest, Genome, Hefei Tianhui, Immutep, Lynk, Oramed, Transcenta.
Read More

In the clinic for May 23, 2023

May 23, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aiviva, Alnylam, Alpine, Anixa, Apnimed, Atyr, Bridgebio, Candel, Corium, Hanall, Hepion, Immix, Medincell, Milestone, Mink, Mirum, Neurimmune, Novartis, Novo Nordisk, Rain, Redhill, Regeneron, Salubris, Vicore.
Read More

In the clinic for May 22, 2023

May 22, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, Boston Scientific, Corvia Medical, EBR Systems, Endotronix, Implicity, Medtronic.
Read More

In the clinic for May 22, 2023

May 22, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Genome, Kymera, Moderna, Painreform, Rocket.
Read More
Previous 1 2 … 135 136 137 138 139 140 141 142 143 … 322 323 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 4, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • Pancreas

    Sonire starts US study of cancer HIFU after $18M series A

    BioWorld
    Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
  • Xray showing lung cancer on tablet

    How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III

    BioWorld
    Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing